“This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month’s treatment, of one dose per week,” he added. It is to be used together with a reduced ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight loss drug similar to Ozempic. Gastroenterologist Dr. Pal Manickam ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

In the December quarter, the company's management said it plans to double the firm's pen capacity over the next couple of ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. In March this year, U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its ...

A STUDENT nurse is one step closer to her dream of having a baby after shedding 115lbs on Mounjaro. Laurie Murray, from Airdrie, started using the weight loss jabs last April when she tipped the ...

A YOUNG woman has revealed that she lost over six stone on Mounjaro but has noticed some very strange side effects. Foxy, a singer and musician from the UK, was able to slim down and lose 6 stone ...

Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and Mounjaro, is undergoing clinical trials. Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

The global diabetes device market is forecast to grow to over $44bn by 2033, according to analysis by GlobalData. Abbott has a 1.4% market share of the CGM market and insulin pen device market ...